Table 2.
Studies registered at the clinical trials registry (http://www.clinicaltrials.gov/) of the United States of America and at the international clinical trials registry platform (World Health Organisation, http://apps.who.int/trialsearch/) concerning the outcome of ADM-assisted breast reconstruction after mastectomy.
| NCT | Status | Location | Expected NR | Principal aim | Radiotherapy |
|---|---|---|---|---|---|
| NCT 00616824 | R | USA | 60 | D versus B | Exclusion criteria |
|
| |||||
| NCT 00639106 | NR | USA | 98 | A versus B | Exclusion criteria |
|
| |||||
| NCT 00692692 | NR | USA | 36 | E versus D | Not named |
|
| |||||
| NCT 00872859 | NR | USA | 196 | A or D with/without RXT | Principal condition |
|
| |||||
| NCT 00956384 | R | Canada | 144 | C versus E | Exclusion criteria |
|
| |||||
| NCT 01027637 | ND | USA | 30 | Defining the stretch parameters of A | Exclusion criteria |
|
| |||||
| NCT 01222390 | NR | USA | 30 | F versus E | Not named |
|
| |||||
| NCT 01310075 | R | USA | 398 | A versus SM | Exclusion criteria |
|
| |||||
| NCT 01372917* | NR | USA | 39 | AM | Exclusion criteria; sterilization with γ-rays |
|
| |||||
| NCT 01561287 | R | USA | 40 | A, neovascularisation | Not named |
|
| |||||
| NCT 01664091 | NR | USA | 32 | ADM versus others, with/without RXT | Principal condition, postsurgery |
|
| |||||
| NCT 01679223 | NR | USA | 60 | AM, incorporation | Not named |
|
| |||||
| NCT 1781299 | R | UK | 50 | A RTU versus SM | Anamnestic record |
|
| |||||
| NCT 01823107 | R | USA | 25 | G | Exclusion criteria |
|
| |||||
| NCT 01853436 | R | Italy | 60 | S | Exclusion criteria |
|
| |||||
| NCT 01959867 | NR | USA | SM versus B | Principal condition, prior to surgery | |
|
| |||||
| ISRCTN 67956295 | NR | UK | 40 | S versus SM | Not named |
A: alloderm; ADM: acellular dermal matrix; AM: allomax; B: traditional reconstruction; C: 1-stage dermal matrix/implant procedure; D: DermaMatrix; E: 2-stage tissue expander/implant procedure; F: ContourProfile© expander; G: Meso BioMatrix Acellular Peritoneum Matrix; ISCTNR: international standard randomised controlled trial number register; NCT: national clinical trial accession number; R: recruiting; NR: not recruiting; RTU: ready to use; RXT: radiation therapy; S: Strattice; SM: Surgimed; UK: United Kingdom; USA: United States of America. *Published results [4].